Validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic-dysfunction associated steatotic liver disease

Markos Kalligeros; Emmanuel A Tsochatzis

doi:10.21037/hbsn-23-654

Validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic-dysfunction associated steatotic liver disease

Hepatobiliary Surg Nutr. 2024 Apr 3;13(2):311-313. doi: 10.21037/hbsn-23-654. Epub 2024 Mar 25.

Authors

Markos Kalligeros¹, Emmanuel A Tsochatzis^{2

3}

Affiliations

¹ Division of Internal Medicine, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI, USA.
² UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, UK.
³ Sheila Sherlock Liver Unit, Royal Free Hospital, London, UK.

No abstract available

Keywords: Fibroscan; cirrhosis; enhanced liver fibrosis (ELF); fibrosis-4 (FIB-4); metabolic-dysfunction associated steatotic liver disease (MASLD).

Publication types

Editorial
Comment